AGN-151607-DP

DRUG2 trials

Sponsors

AbbVie

Conditions

Upper Limb Essential TremorVentral Hernia

Phase 2

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

RecruitingNCT07226791

AbbVieVentral Hernia

Start: 2026-02-04End: 2030-05-01Target: 200Updated: 2026-08-25

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor

RecruitingNCT07673107

AbbVieUpper Limb Essential Tremor

Start: 2026-06-18End: 2028-11-01Target: 94Updated: 2026-06-29